findmyKOL
Clinical trialNCT06745882RecruitingPhase 2Interventional

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

SponsorH. Lee Moffitt Cancer Center and Research InstituteEnrollment318Non-small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a non-registrational, cohort study enrolling eligible Black patients diagnosed with histologically or cytologically, advanced/metastatic NSCLC without known EGFR/ALK/ROS1 tumor mutations, and who are ≥ 18 years of age, ECOG performance status 0-2, and may have detectable ctDNA at baseline.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

    Alberto Chiappori, MDAndreas Saltos, MDBenjamin Creelan, MDBruna Pellini, MDCharles Lu, MDEric Haura, MDJhanelle Gray, MDMichael Shafique, MDSam Vafadar, PA-C, DHScSamantha Klebowski, APRN-CSonam Puri, MDStephanee Smikker, MSPAS, PA-CTawee Tanvetyanon, MDTiffany Apana, MSN, FNP-BC
    Recruiting
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland, United States

    Julie Brahmer, MD
    Recruiting
  • Tidalhealth Peninsula Regional

    Salisbury, Maryland, United States

    Milcah Larks, MD
    Recruiting
  • Montefiore Medical Cancer Center

    The Bronx, New York, United States

    Balazs Halmos, MD
    Recruiting
  • Firsthealth of the Carolinas, Inc.

    Pinehurst, North Carolina, United States

    Charles Kuzma, MD
    Recruiting
  • Baptist Clinical Research Institute

    Memphis, Tennessee, United States

    Osarenren Ogbeide, MD
    Recruiting
  • Nashville General Hospital

    Nashville, Tennessee, United States

    Robin Jacob, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Paclitaxel →Carboplatin →Cisplatin →Pembrolizumab →Pemetrexed →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Jun 2025
Primary completion
31 Jan 2030
Completion
31 Jan 2030
Last update posted
30 Jul 2026
Registered enrollment
318
Registry id
NCT06745882
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.